Get the Stockscreener App
0.2033
4.78%
-0.0102
After Hours:
.20
-0.0033
-1.62%
Beyond Air Inc stock is traded at $0.2033, with a volume of 5.31M.
It is down -4.78% in the last 24 hours and down -19.10% over the past month.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
See More
Previous Close:
$0.2135
Open:
$0.2092
24h Volume:
5.31M
Relative Volume:
3.00
Market Cap:
$19.22M
Revenue:
$1.78M
Net Income/Loss:
$-58.35M
P/E Ratio:
-0.124
EPS:
-1.64
Net Cash Flow:
$-56.66M
1W Performance:
-6.61%
1M Performance:
-19.10%
6M Performance:
-58.52%
1Y Performance:
-83.34%
1-Day Range:
$0.196
$0.2097
1-Week Range:
$0.1905
$0.2184
52-Week Range:
$0.1905
$1.485
Beyond Air Inc Stock (XAIR) Company Profile
Name
Beyond Air Inc
Sector
Industry
Phone
516-665-8200
Address
900 STEWART AVENUE, GARDEN CITY, NY
Compare XAIR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XAIR
Beyond Air Inc
|
0.2033 | 19.22M | 1.78M | -58.35M | -56.66M | -1.64 |
|
ABT
Abbott Laboratories
|
132.82 | 223.47B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.93 | 150.72B | 17.55B | 2.03B | 2.37B | 1.37 |
|
SYK
Stryker Corp
|
378.22 | 139.34B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
84.85 | 107.15B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.65 | 44.54B | 5.54B | 4.18B | 259.90M | 7.00 |
Beyond Air Inc Stock (XAIR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-25-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jul-28-23 | Initiated | Piper Sandler | Overweight |
| Jun-15-23 | Initiated | BTIG Research | Buy |
| Apr-28-21 | Initiated | Truist | Buy |
| Oct-22-19 | Initiated | Oppenheimer | Outperform |
Beyond Air Inc Stock (XAIR) Latest News
Beyond Air Inc (XAIR) Has Recovered 5.0% From Its Low: Is This The Beginning Of A Trend? - Stocksregister
Beyond Air Inc [XAIR] Records 200-Day SMA of $0.3963 - knoxdaily.com
Here is What to Know Beyond Why Alaska Air Group, Inc. (ALK) is a Trending Stock - Nasdaq
A History of Outperforming Analyst Forecasts and Beating the Odds: Beyond Air Inc (XAIR) - Sete News
Charting the Course: Beyond Air Inc’s XAIR Stock Prospects - investchronicle.com
Biosig Technologies Inc: Analyzing BSGM Stock Trends - investchronicle.com
Beyond Air Inc (XAIR) deserves deeper analysis - uspostnews.com
Why Isn't ‘Beyond the Gates’ on Today? - parade.com
An Analysis of Beyond Air Inc (XAIR)’s Potential Price Growth - knoxdaily.com
Lowe’s Cos., Inc [LOW] Stock bought by Insider Simkins Lawrence for $0.25 million - knoxdaily.com
Trading Day Triumph: Beyond Air Inc (XAIR) Ends at 0.22, a 3.67 Surge/Plunge - DWinneX
Crocs Inc [CROX] stock was sold by SISLER SHANNON at the price of US$0.51 million - knoxdaily.com
Potential Price Increase for Tenaris S.A. ADR (TS) After Recent Insider Activity - knoxdaily.com
Beyond Air granted U.S. patent for treatment of NTM infections using gaseous Nitric Oxide - MSN
Beyond Air (XAIR) Secures Patent for Novel Nitric Oxide Delivery Method | XAIR Stock News - GuruFocus
Beyond Air Granted U.S. Patent Covering Treatment of NTM Infections Using gaseous Nitric Oxide (gNO) - The Manila Times
Beyond Air, Inc. Secures U.S. Patent for Novel Nitric Oxide Delivery Method in Treating NTM Lung Infections - Nasdaq
Beyond Air's Breakthrough: New Patent for At-Home NTM Treatment Could Transform Lung Care Through 2038 - Stock Titan
BTIG Research slashes price target on Beyond Air Inc [XAIR] – find out why. - dbtnews.com
Upward Trajectory: Beyond Air Inc (XAIR) Posts a Slidee, Closing at 0.23 - DWinneX
Shares In Beyond Air Inc (XAIR) -35.87% Down, YTD - Marketing Sentinel
Investing in ECARX Holdings Inc (ECX): What You Must Know - knoxdaily.com
XAIR’s price-to-free cash flow ratio: A closer look at its relevance - uspostnews.com
Does Beyond Air Inc (NASDAQ: XAIR) Still Look Hot This Week? - Stocksregister
Beyond Air Unit Receives Orphan Drug Designation for Prospective Phelan-McDermid Syndrome Treatment - marketscreener.com
NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism - The Manila Times
NeuroNOS Secures Exclusive FDA Orphan Drug Rights for Novel Autism-Related Disorder Treatment - Stock Titan
One Hour Heating & Air Conditioning honors local heroes in Hays County and beyond - Hays Free Press
NeuroNOS Appoints Dan Shechtman to Scientific Advisory Board - citybiz
Second Nobel Prize Winner Strengthens NeuroNOS Brain Disease Research Team - Stock Titan
Beyond Air (XAIR) Subsidiary Secures FDA Orphan Status for New T - GuruFocus
BofA Slashes Delta Air Lines Estimates For 2025 And Beyond Amid Capacity, Revenue Challenges - Benzinga
Beyond Air Publishes Article in Annals of the American Thoracic - GuruFocus
Beyond Air Publishes Article in Annals of the American Thoracic Society Journal Highlighting NTM-PD Patients’ Ability to Safely Self-Administer High-Dose Intermittent iNO Treatments Using the LungFit™ GO at Home - TradingView
Breakthrough: New Study Proves Patients Can Safely Self-Treat Severe Lung Disease at Home - Stock Titan
Stock Price Performance And Outlook Of Beyond Air Inc - Marketing Sentinel
Beyond Air, Inc. (XAIR) Reports Q3 Loss, Tops Revenue Estimates - MSN
Is it possible to buy Beyond Air Inc(XAIR) shares at a good price now? - uspostnews.com
Breakthrough: New Research Reveals Promising Early-Stage Alzheimer's Treatment Path - Stock Titan
Beyond Air Announces Vanderbilt University Medical Center as First Luminary Site - The Manila Times
Major Medical Breakthrough: Vanderbilt Implements Beyond Air's Cylinder-Free Nitric Oxide Technology - Stock Titan
A stock that deserves closer examination: Beyond Air Inc (XAIR) - uspostnews.com
Beyond Air Inc (NASDAQ: XAIR) Has Dropped -81.35% So Far This Year. Does That Mean Trouble Ahead? - Marketing Sentinel
Neuronos raises funding to advance NO-regulating therapy for autism - BioWorld MedTech
Valeritas (OTCMKTS:VLRXQ) versus Beyond Air (NASDAQ:XAIR) Head-To-Head Analysis - Defense World
NeuroNOS Secures $2.0 Million in Funding - citybiz
Neuronos gets $2 mln funding for development of autism therapy -March 24, 2025 at 04:33 pm EDT - MarketScreener
NeuroNOS Secures $2.0 Million in Funding to Advance Development of an Innovative Autism Therapy - The Manila Times
NeuroNOS Secures $2 Million in Funding - citybiz
Breakthrough Autism Therapy Shows Promise: NeuroNOS Raises $2M for Game-Changing Treatment - Stock Titan
Beyond Air (XAIR): Among the Penny Stocks With Huge Upside Potential According to Analysts - Insider Monkey
Beyond Air Inc Stock (XAIR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):